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Huntington´s disease (HD) is a progressive, neurodegenerative disease with fatal outcome. Although the disease-
causing gene (huntingtin) has been known for some time, the exact cause of neuronal cell death is still unknown. 
One potential mechanism contributing to the massive loss of neurons in the brain of HD patients might be the 
unfolded protein response (UPR), which is activated by accumulation of misfolded proteins in the endoplasmatic 
reticulum (ER). As an adaptive response to counter-balance accumulation of un- or misfolded proteins, the UPR 
upregulates transcription of chaperones, temporarily attenuates new translation, and activates protein degradation 
via the proteasome. However, it is known that persistent ER stress and activated UPR can cause cell death by 
triggering of apoptosis. Nevertheless, the evidence linking UPR with HD progression remains inconclusive. Here, we 
present first analyses of UPR activation during HD based on available expression data. To elucidate the potential 
role of UPR as a disease-relevant process, we examine its connection to cell death and inflammatory processes. Due 
to the complexity of these molecular mechanisms, a systems biology approach was pursued. 
HD is an autosomal-dominant neurodegenerative disorder. 
Its symptoms are loss of motor control, cognitive decline, 
and behavioral abnormalities. For most cases, the disease 
onset is between the age of 35 and 50. The outcome is fatal 
with life expectancy after disease onset of around 20 years 
only. The treatment of HD has remained symptomatic, as 
no cure exists to date.  
The cause of HD is a mutation in a single gene called 
huntingtin. In HD patients, a expansion of the CAG repeat 
in exon 1 of huntingtin has been identified [1]. It results in a 
long stretch polyglutamine close to the N-terminus of the 
Huntingtin protein (Htt) which is involved in multiple 
molecular functions. Although the molecular cause has 
been known now for almost 20 years, the exact mechanisms 
leading to the observed massive cell death of neurons in the 
caudate nucleus of HD patients still need to be determined. 
A variety of processes such excitotoxicity, protein 
aggregation and transcriptional dys-regulation have been 
suggested to be involved in neurodegeneration in HD. Only 
recently, studies have indicated that the ER stress and UPR 
might be linked to neurodegenerative diseases. 
 
ER stress and UPR  
The endoplasmic reticulum (ER) is a crucial organelle for 
correct folding and modification of numerous proteins. 
Accumulation of unfolded or misfolded protein causes a 
stress signal in the ER [2]. For HD, experimental evidence 
suggests that cytosolic mHtt fragments strongly impair 
endoplasmic reticulum (ER)-associated protein degradation 
(ERAD), as mHtt entraps ERAD proteins [3]. As the 
protein degradation is impaired, misfolded proteins might 
accumulate in the ER inferring with its correct functing. To 
ensure fidelity of protein folding, several transcriptional 
and translational mechanisms are activated during the 
Unfolded Protein Response (UPR) which senses when the 
ER exceeded its capacity for correct folding. UPR stress 
sensors Inositol-requiring protein-1(IRE1), activating 
transcription factor 6 (ATF-6) and PKR-like ER kinase 
(PERK are subsequently activated. As an adaptive response 
to counter-balance accumulation of un- or misfolded 
proteins, the UPR upregulates transcription of chaperones, 
temporarily attenuates new translation, and activates protein 
degradation via the proteasome [4]. The main function of 
the UPR is re-establishing homeostasis by increasing the 
folding capacity. 
Though the primary role of UPR is up-regulation of 
chaperones, persistent ER stress can mediate toxicity and 
eventually lead to apoptosis through activation of JNK, 
ASK1 and caspase-12. Remarkably, recent studies have 
also suggested that ER stress and activated UPR are 
interconnected with inflammatory processes [5]. Notably, 
secreted inflammatory cytokines and activated microglia 
cells could possibly lead to axonal damage and extensive 
neuronal cell death in HD pathology [6-9]. A scheme of the 
different mechanisms triggered by ER stress in the context 
of HD can be found in figure1. 
As a potentially important process in HD progression, we 
examined therefore the activation of UPR during HD, and 
cross-talk between UPR and neurodegeneration in HD. Due 
to the complexity of these processes, we have started to 
develop explicit models for the interconnections between 
ER stress and apoptosis or neuroinflammation. Based on 
these models, we can suggest defined set of follow-up 
experiments to further clarify the role of UPR signaling 
related to pathophysiology in HD. As lowering of stress 
might prove beneficial, our objectives are a) to investigate 
the participation of molecular signaling networks and b) to 
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The UPR signaling network 
To determine possible implications of the UPR in HD, 
we seek to assess its activation using a computational 
approach and the evaluation of existing data. As a first 
step, the UPR signaling pathway has been reconstructed 
based on a literature review. The main branches are via 
ATF6, PERK and IRE1.  
Although several main components have been well 
studied, it is less clear how alternative branches of the 
UPR are coordinated. Therefore, we have complemented 
the canonical UPR pathway with additional protein 
interaction data to represent its embedding into the cellular 
context and to identify potential modifiers. To this end, we 
have utilized the Unified Human Interactome (UniHI) 
database (www.unihi.org) to obtain interaction partners for   
EIF2AK3, ATF6, ERN1 and ATF4. The retrieved set of 
interactions partners defined a core set of proteins for the 
UPR (table 1). Figure 2 displays the derived UPR network 
consisting of 26 proteins. 
 
Potential activation of UPR in HD 
Since changes in gene transcription are main effects of 
UPR activation and published microarray data is available 
for different stages of HD in humans as well as for HD 
model, we used 3 different gene expression datasets in 
this study. Two datasets included expression for HD 
mouse models [10,11] and one dataset included 
expression for human HD brains and controls [12]. All 
data was obtained from  the NCBI GEO database 
(GSE10263, GSE3621 and GSE 3790) and analyzed 
using the R/Bioconductor platform. 
 
To identify an expression signature for potential 
activation of the UPR in HD, we collected a set of 
known UPR target genes through literature review. To 
check whether these genes have ER stress elements 
(ERSE:CCAAT(N9)CCACG) and UPR elements 
(UPRE:CNTNKNNG)(GRAMYKGR)(ATACGGAG)) 
in their promoter sequences, we additionally obtained 
promoter sequences (+5000 to -1000 bp) from 
TRANSFAC database and search them for ERSE and 
UPRE sequences.  
 
Our initial analysis indicates that indeed the ER stress 
and UPR related genes are regulated during early stages 
of the HD and most of genes involved in UPR posses 
UPRE element (Figure 2) in their promoter and these 
elements play crucial role in the regulating these genes, 
although this expression signature needs further study. 
 
Cross-talk between UPR and apoptosis 
The set of genes involved in apoptosis was defined by 
the corresponding KEGG pathway. In order to identify 
cross-talk between UPR and apoptosis, we have 
distinguished genes that are either directly (core UPR 
and core apoptosis genes) or indirectly (extended UPR 
and extended apoptosis genes) involved in both UPR 
and apoptosis. Finally, we ended up with 26 core UPR 
Figure 1. HD and possible UPR-associated 
mechanisms during disease progression. 
Mutant Huntingtin can interfere with ER-
associated degradation (ERAD) resulting in 
accumulation of misfolded protein in the ER 
and thus in the activation of the UPR [3]. As 
an adaptive response, the UPR up-regulates 
transcription of chaperones, temporarily 
attenuates new translation, and activates 
protein degradation via the proteasome. 
Persistent levels of ER stress, however, may 
trigger inflammatory pathways as well as 
caspase activation and may ultimately lead to 
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 genes, 62 core apoptosis genes, 682 genes in extended 
UPR and 1414 genes in extended apoptosis (Figure 4). 
Genes common to UPR and apoptosis are primary 
candidates constituting a cross-talk between both 
processes. Examination of the interaction networks 
indeed revealed that three proteins are associated with 
UPR as well as apoptosis (Figure 5): 
 TRAF2 (TNF receptor-associated factor 2): ER 
stress-induced neuronal death can be activated by 
binding of ASK1 to the complex of IRE1 and 
TRAF2 [13].  
 IKBKB (IκB-kinase beta): Phosphorylation of IkB 
proteins by IKBKB leads to their ubiquitination 
and destruction, thereby allowing activation of the 
NF-kappa-B complex. 
 
 BAX (BCL2-associated X protein): This protein 
forms a heterodimer with BCL2, and acts as an 
apoptotic activator. 
For a more complete representation of UPR-induced 
apoptosis, we intend to construct a dynamic network 
representation. Such model may also serve as rationale 
basis for experimental studies. 
Gene symbol Gene Name Binding partner 
EIF2AK3  ATF6     ERN1 ATF4 
ATF6     activating transcription factor 6        
ATF6B activating transcription factor 6 beta  ●   
BAK1  BCL2-antagonist/killer 1     ●  
BAX  BCL2-associated X protein     ●  
BCL6  B-cell CLL/lymphoma 6 (zinc finger protein 51)   ●    
COPS5  COP9 constitutive photomorphogenic homolog subunit 5    ●  
CREB3L3  cAMP responsive element binding protein 3 like 3    ●   
DNAJC3  DnaJ (Hsp40) homolog, subfamily C, member 3   ●    
EIF2AK3  Eukaryotic translation initiation factor 2-alpha kinase 3      ● 
EIF2S1  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa   ●   ● 
ERN1  endoplasmic reticulum to nucleus signalling 1       
GTF2I  General transcription factor II-I    ●   
GTPBP2  GTP binding protein 2    ●   
HSP90AA1  Heat shock protein HSP 90-alpha (HSP 86)   ●  ●  
HSP90B1  heat shock protein 90kDa beta (Grp94), member 1   ●    
HSPA5     heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)    ●  ●  
IKBKB  Inhibitor of nuclear factor kappa B kinase beta subunit   ●    
MAP3K5  mitogen-activated protein kinase kinase kinase 5     ●  
NFE2L2  nuclear factor (erythroid-derived 2)-like 2   ●    
NFYC  nuclear transcription factor Y, gamma    ●   
PSEN1  presenilin 1     ●  
SRF  serum response factor   ●   
TAOK3  TAO kinase 3     ●  
TRAF2  TNF receptor-associated factor 2     ●  
XBP1  X-box binding protein 1    ●   
YY1  YY1 transcription factor    ●   
 
Table 1: List of proteins in the UPR signaling network. Physical protein-protein interactions with  EIF2AK3, 
ATF6, ERN1 and ATF4 as derived from the UniHI database are noted.  
 
 
Figure 2: Protein interaction network for the UPR. Gray nodes represent the central UPR proteins EIF2AK3, 
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Figure 3: Expression of UPR–associated genes in HD mouse models (1-5 columns from left) and human 
HD patients (6th column). Up-regulation is represented by shades of red, down-regulation is represented 
by shades of green. Additionally, the presence of ERSE and UPRE in the promotor regions is indicated: 
+’= present; ‘-’= absent. 
 
Figure 4: Venn diagram for core and extended UPR and apoptosis network. Extended UPR and apoptosis 
includes proteins that physically interact with core proteins. Interactions were derived from the UniHI 
database.  
 
Figure 5: Network representation of core UPR and apoptosis. UPR proteins with interactions to apoptosis 
were shaded by dark green, apoptosis protein with interactions to UPR by dark purple. Interconnecting 
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Neuroinflammation in HD 
Inflammation is a immunological process usually 
carried out by the blood vascular system to counteract 
disease, and to fight foreign antigens against invasion. 
Within the brain, microglia and astrocytes play 
important immunological functions. Until very recently 
little was known about inflammatory molecules in HD.  
Recent studies, however, revealed a distinct profile of 
inflammatory mediators from post-mortem human HD 
tissue [6,7]. Important in this context are following 
observations:  
 In general, activated microglia exert their diverse 
effects on neurons and macroglia (astrocytes and 
oligodendrocytes) through the release of 
cytoprotective agents such as growth factors, 
plasminogen, and neuroprotective cytokine as well 
as cytotoxic substances such as oxygen radicals, 
nitric oxide, glutamate, proteases, and neurotoxic 
cytokines. Notably, one of the earliest reports 
describing microglial abnormalities in HD was by 
Singhrao et al [9]. Inflammatory mediators such as 
IL-1β and TNF-α were increased only in the 
striatum, whereas IL-6, IL-8 and MMP-9 were also 
upregulated in cortex and in the cerebellum [7]. 
 Microglial cell counts were considerably increased 
in the caudate putamen of HD and these microglial 
cells expressed increased amounts of complement 
factors [9]. A more detailed investigation of 
microglial morphological changes associated with 
HD was performed by Sapp et al. [14]. The authors 
localized morphologically activated microglial cells 
in the neostriatum, cortex and globus palidus as well 
as in adjoining white matter of HD brains. 
Additionally, PET studies using the ligand for 
benzodiazepine receptor (PK-11195), which labels 
activated microglia have been employed to study of 
neuroinflammation. Using this technique, Tai et al 
[15,16] demonstrated that microglial activation in 
HD patients correlates with disease progression as 
assessed by loss of dopamine D2 receptor binding 
sites. Interestingly Tai et al. could also demonstrate 
that microglial activation and release of cytokine IL-
6 is observed in presymptomatic HD gene carriers 
and can be detected up to 15 years before predicted 
age of onset. These findings indicate the microglial 
inflammatory activation is an early event associated 
with subclinical progression of HD and may 
constitute a target for early therapeutic intervention. 
 Earlier studies performed by one of us in Alzheimer 
disease observed strong correlations of redox 
alterations to inflammatory stress responses [17,18]. 
Here, we demonstrated an intermediary signaling 
role of ceramide in activation of stress kinase 
cascades linking oxidative stress with inflammatory 
induction of enzymes iNOS, COX-2 with the release 
of NO, and pro-inflammatory cytokines TNF-α, IL-
1β  and IL-6. Inhibition of ceramide generation and 
or pro-oxidant responses by use of ceramide 
synthesis blocker (such as fumonisin B1, 
sphingomyelinase inhibitors 3-o-methyl 
sphingomyelin), and anti-oxidant Vitamin E, 
completely prevent these proinflammatory stress 
responses. In this context, AICAR, an AMP kinase 
activator, has demonstrated has a therapeutic 
potential in curbing proinflammatory responses as 
well preventing neuronal cell apoptosis [18].  
 
Possible experimental follow-up 
Based on the undertaken review, we hypothesize that 
mHtt generated ER stress might lead to apoptotic  
cascades in neuronal stress and might trigger 
inflammatory stress responses in adjacent glial cells in 
the diasease pathogenesis. A first experimental analysis 
in primary glial cells could elucidate the inflammatory 
stress in HD pathology. Initially, it is important to 
examine the role of mHtt in microglia cells i.e. to 
determine whether mHtt leads to ER stress in microglia. 
In case of UPR activation, the LPS/Smase dependent 
cytokine and chemokine release can be measured to 
verify inflammatory signaling. An interesting sideline 
would be whether occurrence of ER stress might be 
correlated with mitochondrial stress [19,20]. Hence, it is 
would be relevant to demonstrate possible alterations in 
mitochondrial protein expression and measurement of 
redox indicators (reduced glutathione, generation of 
reactive oxygen species as well expression of redox 
regulating enzymes such as superoxide dismutases 
(Cu/Zn and Mn-SOD, catalase). Finally, the role of 
excitotoxic glutamate release mechanisms in neuronal 
cell death and apoptosis is of relevance here, as glial 
cell dysfunction and associated inflammatory stress 
responses might cause imbalances in glutamate/calcium 
homeostasis [21]. Figure 6 presents an initial working 
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